Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Accumulated Expenses (2016 - 2026)

Perspective Therapeutics' Accumulated Expenses history spans 16 years, with the latest figure at $3.9 million for Q1 2026.

  • On a quarterly basis, Accumulated Expenses rose 33.1% to $3.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $3.9 million, a 33.1% increase, with the full-year FY2025 number at $7.5 million, up 36.71% from a year prior.
  • Accumulated Expenses hit $3.9 million in Q1 2026 for Perspective Therapeutics, down from $7.5 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for CATX hit a ceiling of $7.5 million in Q4 2025 and a floor of $253000.0 in Q2 2022.
  • Historically, Accumulated Expenses has averaged $2.8 million across 5 years, with a median of $2.6 million in 2024.
  • Biggest five-year swings in Accumulated Expenses: dropped 2.32% in 2022 and later soared 1158.95% in 2023.
  • Tracing CATX's Accumulated Expenses over 5 years: stood at $285000.0 in 2022, then soared by 1158.95% to $3.6 million in 2023, then skyrocketed by 52.68% to $5.5 million in 2024, then surged by 36.71% to $7.5 million in 2025, then tumbled by 48.24% to $3.9 million in 2026.
  • Business Quant data shows Accumulated Expenses for CATX at $3.9 million in Q1 2026, $7.5 million in Q4 2025, and $6.7 million in Q3 2025.